0001415889-22-012324.txt : 20221209
0001415889-22-012324.hdr.sgml : 20221209
20221209163305
ACCESSION NUMBER: 0001415889-22-012324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221207
FILED AS OF DATE: 20221209
DATE AS OF CHANGE: 20221209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Javitt Jonathan C
CENTRAL INDEX KEY: 0001303782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38302
FILM NUMBER: 221455268
MAIL ADDRESS:
STREET 1: 1201 NORTH MARKET STREET
STREET 2: SUITE 111
CITY: WILMINGTON
STATE: DE
ZIP: 19801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001719406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822844431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 484-254-6134
MAIL ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp.
DATE OF NAME CHANGE: 20171012
4
1
form4-12092022_091256.xml
X0306
4
2022-12-07
0001719406
NRX Pharmaceuticals, Inc.
NRXP
0001303782
Javitt Jonathan C
C/O NRX PHARMACEUTICALS, INC.
1201 NORTH MARKET STREET, SUITE 111
WILMINGTON
DE
19801
true
false
true
false
Common Stock, par value $0.001 per share
2022-12-07
4
S
0
400000
1
D
12899997
I
By Trust
Common Stock, par value $0.001 per share
1422000
I
By Trust
Common Stock, par value $0.001 per share
146332
D
Private sale pursuant to an option granted by the Reporting Person in 2017 in support of a financing for NeuroRx, Inc. Purchaser has agreed to hold the shares for a period of one year.
Held by the Jonathan Javitt Living Trust. The Reporting Person is a trustee of the Trust.
Held by the Javitt 2012 Irrevocable Dynasty Trust. The Reporting Person is the grantor of the Trust.
/s/ Jonathan C. Javitt
2022-12-09